← All trials
NCT05022329
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2021
- Primary completion
- Sep 30, 2022
- Completion date
- Sep 30, 2023
- First posted
- Aug 26, 2021
- Last posted
- Nov 23, 2021
- Enrollment
- 300
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of TorontoLead sponsor
- University of TorontoCollaborator
- University of TorontoCollaborator
- Providence Health & ServicesCollaborator
- Unity Health TorontoCollaborator
- Scarborough General HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.